Skip to main content

Advanced Search

Projected result for your current search:: 0

Search Operators:

You can use operators in your search query to narrow down your results even more. Click on the search operator to see an explanation of how it works.
Finds documents with exactly this word group, in exactly this word order and spelling (e.g. "employer branding").
Finds documents with both search terms (e.g. sales AND bonus).
Finds documents with one or the other search term (e.g. porsche OR volkswagen).
Finds documents with all search terms. Blank space is understood as AND (e.g. man robot production).
Finds documents with no appearance of the word behind NOT (e.g. ford NOT "harrison ford").
Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g. COUNT(gear)>8).
Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g. NEAR(recruit, professionals, 20)).
Finds documents with the search term in word versions or composites. The asterisk * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g. lightweight*, *lightweight, *lightweight*).
Finds documents with the search term in different spellings. "?" allows only one character (e.g. organi?ation).
Special characters are understood as AND (e.g. Miller Bros. & Sons).
 Log in
Top

Drugs

Issue 2/2025

Content (12 Articles)

The Future of Microbiome Therapeutics

  • Open Access
  • Current Opinion

Milena Pitashny, Inbar Kesten, Dima Shlon, Dana Ben Hur, Haggai Bar-Yoseph

Tuberculosis Preventive Treatment in High TB-Burden Settings: A State-of-the-Art Review

Violet Chihota, Makaita Gombe, Amita Gupta, Nicole Salazar-Austin, Tess Ryckman, Christopher J. Hoffmann, Sylvia LaCourse, Jyoti S. Mathad, Vidya Mave, Kelly E. Dooley, Richard E. Chaisson, Gavin Churchyard

Efficacy and Safety of CDK4/6 Inhibitors: A Focus on HR+/HER2− Early Breast Cancer

Eva Valentina Klocker, Daniel Egle, Rupert Bartsch, Gabriel Rinnerthaler, Michael Gnant

Current and Emerging Therapies for Lysosomal Storage Disorders

Diego Agustín Abelleyra Lastoria, Sophie Keynes, Derralynn Hughes

Treatment of Complicated Gram-Positive Bacteremia and Infective Endocarditis

Paul Schellong, Oana Joean, Mathias W. Pletz, Stefan Hagel, Sebastian Weis

Buprenorphine Pharmacodynamics: A Bridge to Understanding Buprenorphine Clinical Benefits

Mellar Davis

Aligning Large Language Models with Humans: A Comprehensive Survey of ChatGPT’s Aptitude in Pharmacology

  • Open Access
  • Original Research Article

Yingbo Zhang, Shumin Ren, Jiao Wang, Junyu Lu, Cong Wu, Mengqiao He, Xingyun Liu, Rongrong Wu, Jing Zhao, Chaoying Zhan, Dan Du, Zhajun Zhan, Rajeev K. Singla, Bairong Shen

Liposomal Irinotecan: A Review as First-Line Therapy in Metastatic Pancreatic Adenocarcinoma

Michael B. Brown, Hannah A. Blair

Marstacimab: First Approval

Yvette N. Lamb

Inavolisib: First Approval

Hannah A. Blair

Comment on: “The Utilization of the Accelerated Approval Pathway in Oncology: A Case Study of Pembrolizumab”

  • Letter to the Editor

Raffaele Giusti

Correction: Fulzerasib: First Approval

  • Correction

Yvette N. Lamb

Jan 25
Issue: 1/2025
Mar 25
Issue: 3/2025

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more